Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pasireotide lowers plasma ACTH levels in patients with Nelson's syndrome

April 7, 2016

High-affinity Fab XOMA-129 shows promise in hypoglycemia models

April 6, 2016

Bristol-Myers Squibb patent describes free fatty acid receptor agonists

April 6, 2016

Intrexon creates joint venture to develop treatment for type 1 diabetes

April 5, 2016

Single-dose and preservative-free formulation of Makena launched in the U.S.

April 5, 2016

CHMP recommends approval of Strimvelis for ADA-SCID

April 4, 2016

Amicus' migalastat gets positive opinion from EMA for Fabry disease

April 4, 2016

Guizhou Bailing Group Pharmaceutical discloses alpha-glucosidase inhibitors

April 4, 2016

Celimmune initiates phase II study of AMG-714 for refractory celiac disease type II

April 1, 2016

Radius Health submits NDA for abaloparatide for postmenopausal osteoporosis

March 31, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...